CN208405629U - The drug storage of nebulizer administration and atomising device - Google Patents

The drug storage of nebulizer administration and atomising device Download PDF

Info

Publication number
CN208405629U
CN208405629U CN201720845057.0U CN201720845057U CN208405629U CN 208405629 U CN208405629 U CN 208405629U CN 201720845057 U CN201720845057 U CN 201720845057U CN 208405629 U CN208405629 U CN 208405629U
Authority
CN
China
Prior art keywords
atomization
mould group
medicine glass
medicine
atomized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201720845057.0U
Other languages
Chinese (zh)
Inventor
王成
陆阳
唐盛高
陆春
龙志峰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Changzhou Zhengyuan Medical Technology Co ltd
Suno Biomedical Technology Guangzhou Co ltd
Original Assignee
Changzhou Zhengyuan Medical Technology Co ltd
Guangzhou Nanotides Pharmaceuticals Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Changzhou Zhengyuan Medical Technology Co ltd, Guangzhou Nanotides Pharmaceuticals Co ltd filed Critical Changzhou Zhengyuan Medical Technology Co ltd
Priority to CN201720845057.0U priority Critical patent/CN208405629U/en
Application granted granted Critical
Publication of CN208405629U publication Critical patent/CN208405629U/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Catching Or Destruction (AREA)

Abstract

The utility model discloses a kind of drug storage of nebulizer administration and atomising devices, comprising: medicine glass mould group comprising has the medicine glass for holding the cavity of medical fluid, offers the atomization mouth communicated with the cavity on the medicine glass;It is atomized mould group comprising for by the atomization part of medical liquid atomizing;Isolated part, for only allowing medical fluid to contact the atomization part in atomized medicine introducing between the atomization mouth and the atomization mould group;In atomized medicine introducing state, isolated part is pulled out, removes or destroys for the drug storage and atomising device, and medical fluid and atomization part contact in medicine glass, the medicine glass mould group further includes first connecting portion part for connecting atomization plant host;The atomization mould group further includes the second connecting portion part for connecting atomizing face mask or suction nozzle.Eliminate it is medicinal atomized it is complete after cleaning step, avoid to prolong its service life because of drug cross contamination caused by not washing clean clearly, and the loss for reducing atomization plant host itself.

Description

The drug storage of nebulizer administration and atomising device
Technical field
The utility model belongs to nebulizer administration field, the in particular to drug storage and atomization of a kind of nebulizer administration Device.
Background technique
Inhalation in Treating mitigate respiratory disease such as asthma, chronic obstructive pulmonary disease and in terms of play weight It acts on, the treatment for specified disease, inhalation has more advantage than other administration modes, is more especially easy in enteron aisle In the macromolecular drug that is degraded, is influenced by liver first-pass effect, be more suitable for reaching the breathing area of lung by inhalation. There are three types of the methods of inhalation at present for inhalation: dosage metered dose inhaler (MDI), Foradil Aerolizer formoterol fumarate (DPI) and atomizer (nebulizer).Wherein, nebulizer administration is since good, easy to operate with atomizing effect, noise is small, small in size portable etc. Advantage, clinical application are more and more extensive.
Atomisation administration be, due to atomizing effect, operability, in terms of have unique advantage and by pass Note is widely used in the various respiratory diseases for the treatment of even other systems disease in clinic.Atomizer is using liquid spray Form drug drop is sent to the device of lung, drug solution or suspension are broken using oxygen, compressed air or ultrasonic method The balance at liquid interface designs in conjunction with specific atomizing component and structure, promotes medical liquid atomizing to form small liquid particles (so-called " mist "), respiratory tract and lung are sucked by suction nozzle.
Neulized inhalation compares other administration modes, mainly has the advantage that the drug of (1) sucking can be directly to up to respiratory tract And lung, it is directly entered blood through pulmonary capillary, therefore more rapid-action than oral drugs, and more effective;(2) due to drug Directly enter respiratory tract through sucking, and be directly entered blood through pulmonary capillary, avoids the first pass effect of liver, dosage is most / 10th of the more other administration modes of need, it will be apparent that reduce the toxic side effect of drug, this point is for children and old man It is particularly important;(3) humidifying airway dilutes sputum, can be commonly used to various respiratory diseases;(4) felt for certain with virus It is based on dye, can self-healing disease (as catch a cold), atomization inspiration treatment can substantially reduced symptom, shorten the course of disease;(5) drug effect Directly, rapid-action, to alleviation bronchial asthma significant effect and rapidly, it is better than other treatment mode, or even in clutch energy Enough save the life of patient.
The target of atomization inspiration treatment is that the drug of therapeutic dose is (logical in the relatively short time in a manner of atomizing particle Often be 5-15 minute) in importing respiratory tract or lung.In atomization process, the medicine glass of specific volume is as receiving drug solution Container, after container privileged site is opened, medical fluid is contacted with atomizing piece, realizes the high-efficient atomizing to medical fluid.With enteron aisle or other are non- Intestinal canal administration is compared, and has various advantages: quick acting by nebulizer administration, and reducing therapeutic dose reduces toxic side effect Deng, therefore it is now widely used in clinical or residential care, the therapeutic administratp mode as specified disease.
Atomized inhalation includes various solution or liquid suspension dosage form, specific auxiliary material is added in drug to realize that drug is controlled The target for the treatment of.Atomized solns or suspension all at present is all sterile, majority packing in the form of unit dosage, Avoid the pollution of antibiotic or microorganism.One typical sucking atomizer product includes soup holding device (atomizing cup), gear Plate, host (or compression set), suction nozzle or mask containing atomizing piece etc..
Currently, atomizing piece is used as the non-removable a part of atomization host in clinical or household atomization system, Medical fluid is put into atomizing cup when use, atomizing piece is contacted with liquid medicine, realizes atomization by compression or ultrasonic technique.In this way It is necessary to clean to atomizing piece after being often administered once, excessive cleaning step is not only made troubles to user, can also be increased The loss of atomising device accelerates the aging of atomizing piece, once atomising device or atomizing piece are out of order, will face entire atomizer Abandon.Meanwhile a component of the atomizing piece as atomizer, it is exposed in environment for a long time, is easy by bacterium, fungi, resists The pollution of the various harmful substances such as raw element, even if can not also thoroughly remove pollutant by disinfection, this is to requiring sterile drug The atomization of solution is very unfavorable.In addition, being atomized using conventional atomizers to drug, different pharmaceutical is easy to produce friendship when treating Fork pollution, largely effects on the therapeutic effect of disease.
Utility model content
Under the premise of comprehensively considering various aspects factor, the utility model proposes a kind of drug storage of nebulizer administration and Atomising device, be not required to atomization part clean, can integral replacing without being impacted to atomization plant host.
The technical solution adopted in the utility model is as follows:
A kind of drug storage of nebulizer administration and atomising device, comprising:
Medicine glass mould group comprising there is the medicine glass for holding the cavity of medical fluid, offered and the chamber on the medicine glass The atomization mouth that body communicates;
It is atomized mould group comprising for by the atomization part of medical liquid atomizing;
Isolated part, for only allowing medical fluid in atomized medicine introducing between the atomization mouth and the atomization mould group Contact the atomization part;
Wherein, the drug storage and atomising device have atomized medicine introducing state, in atomized medicine introducing state, the isolated part quilt It detaches, remove or destroys, medical fluid and atomization part contact in the medicine glass,
The medicine glass mould group further includes first connecting portion part for connecting atomization plant host;The atomization mould group is also wrapped Include the second connecting portion part for connecting atomizing face mask or suction nozzle.
Preferably, the isolated part is selected from one or more of cap, encapsulating film and membrane layer;Wherein:
The cap is connected on the wall of cup of the medicine glass to close the atomization mouth, and the cap have by The weak point being broken after to external force;
The encapsulating film be arranged in being pulled out, be squeezed and deformed or puncture between the medicine glass and the atomization mould group or On the medicine glass or in the atomization mould group;
The membrane layer covering is formed on the atomization part and can be destroyed or remove.
Preferably, the atomization part is piezoelectric ceramic atomizer patch, is distributed on the piezoelectric ceramic atomizer patch a large amount of micro- Hole.
It is highly preferred that described first connecting portion part includes at least a pair of for connecting with the atomization plant host to obtain The access probe of electric signal.
Further, the medicine glass is equipped with the conductive spy of at least a pair first of electrical connection corresponding with the access probe Needle, the atomization mould group include that at least a pair of second conducting probe of electric signal is provided to the piezoelectric ceramic atomizer patch, work as institute Atomized medicine introducing device is stated in atomized medicine introducing state, first conducting probe and second conducting probe connect.
Further, the atomization mould group includes that at least a pair second of electric signal is provided to the piezoelectric ceramic atomizer patch Conducting probe, when the atomized medicine introducing device is in atomized medicine introducing state, the access electric probe passes through conducting wire and described second Conducting probe connects.
Preferably, there is at least one circle to outward extend flange, the flange surrounds the mist on the outer wall of the medicine glass Change mouth setting, the isolated part is arranged on the flange.
It is highly preferred that the flange includes inward flange and outward flange, the inward flange is arranged around the atomization mouth, described Outward flange is arranged around the inward flange, and the isolated part includes cap and encapsulating film, and the cap is arranged described On inward flange and the cap has the weak point being broken after by external force, and the encapsulating film is arranged on the outward flange And it can be punctured or be squeezed and deformed.
Preferably, the second connecting portion part includes atomizing face mask seat.
Preferably, it is also provided with air hole on the medicine glass, the medicine glass is equipped with for closing the air hole and can It is removed and exposes the medicine glass cap of the air hole.
Medicine glass mould group described in the utility model and atomization mould group, the two are combined with each other into a kind of pair of drug solution and are atomized Device.The atomization mouth of medicine glass removes encapsulating film and cap, and after atomization mould group removes atomization mould group bottom cover, the two is mutually right It connects, comes into full contact with medical fluid and atomizing piece in medicine glass.It, can be by each after connecting the atomization plant host for being free of atomizing piece Kind method driving atomization, the including but not limited to means such as injection, mesh or ultrasound, realize the atomization to medical fluid.Preferably, described Medicine glass mould group and atomization mould group are independent components, are atomized using preceding by realizing after seamless interfacing to medical fluid.Further preferably , the atomization driving force of the atomization mould group is mesh atomization.
Medicine glass mould group described in the utility model, body shape can for it is cylindrical, conical, cube shaped or by The enclosed construction of certain surface and side composition, pref. cylindrical structure.The atomization mouth position of medicine glass is the side on medicine glass surface Or bottom.Preferably, atomization mouth is located at the side wall of medicine glass, for round prominent structure.There is atomization in the middle part of the medicine glass atomization mouth Mouth cap, atomization mouth outside portion are that medicine glass is atomized mouth encapsulating film.Medicine glass, which is atomized mouth, can also be located at medicine glass bottom, at this time medicine glass Cap is sunk structure, and medicine glass is enable normally steadily to place.
Atomization mould group described in the utility model is equipped with atomizing piece in side, is atomization mould group bottom cover on the outside of atomizing piece, uses In being isolated from the outside, bacterium or noxious material is avoided to pollute.Preferably, the atomizing piece is piezoelectric ceramic thin sheet.It is further excellent Choosing, there are particular size, netted equally distributed microcellular structure on the piezoelectric ceramic atomizer patch.It is further preferred that described The size of micropore is 5 microns or less.
The overall structure that atomization mould group described in the utility model can be combined into one with medicine glass recycles external independent The medical fluid in medicine glass is atomized in the atomization plant host of the utility model.At this point, medicine glass mould group is without containing atomization mouth envelope Capping and conducting probe, and encapsulating film is only set.And the conducting probe being atomized in mould group directly passes through in conducting wire and medicine glass mould group Access probe be connected.Remove or destroy medicine glass atomization mouth encapsulating film using ad hoc fashion before atomization.Atomization is free of when connecting After the atomization plant host of piece, it is directly realized by the atomization to medical fluid.
Above-mentioned overall structure can also not contain encapsulating film, at this time between the atomizing piece of atomizing component and medicine glass component There is membrane layer, for atomizing piece and medical fluid to be isolated.
The inseparable overall structure that above-mentioned atomizing piece mould group and medicine glass die combination are integrated, either encapsulating film still every Film layer must be destroyed or be removed in a specific way before atomization, and the destruction or removing method include but is not limited to puncture, squeeze It presses, detach, so that medical fluid be made directly to contact with atomizing piece, realize the atomization to drug.
Above-mentioned inseparable overall structure can be used as the case that drug solution in medicine production process is held.? In this overall structure, atomizing component can be located at top, the side or bottom of medicine glass component.
The utility model uses above scheme, has the advantages that compared with prior art
It will be atomized the medicine glass composition corollary apparatus that mould group is independent from atomization plant host, with medical fluid is contained, saved It is medicinal atomized it is complete after cleaning step, avoid because of drug cross contamination caused by not washing clean clearly, and reduce atomization plant The loss of host itself can prolong its service life.In addition, mould group will be atomized and contains the medicine glass of atomization medical fluid as a set of only Vertical device can also accurately quantify drug dose while being easy to use, and reduce error, improve drug effect.
Detailed description of the invention
It, below will be to needed in embodiment description in order to illustrate more clearly of the technical solution of the utility model Attached drawing is briefly described, it should be apparent that, the drawings in the following description are merely some embodiments of the present invention, for For those of ordinary skill in the art, without creative efforts, it can also be obtained according to these attached drawings other Attached drawing.
Attached drawing 1 is a kind of drug storage of nebulizer administration of the utility model embodiment 1 and the cross-sectional view of atomising device;
Attached drawing 2 is a kind of drug storage of nebulizer administration of the utility model embodiment 1 and the exploded view of atomising device;
Attached drawing 3 is a kind of drug storage of nebulizer administration of the utility model embodiment 2 and the cross-sectional view of atomising device;
Attached drawing 4 is a kind of drug storage of nebulizer administration of the utility model embodiment 3 and the cross-sectional view of atomising device.
In above-mentioned attached drawing,
1, medicine glass;11, upper cover;110, air hole;111, breather hole cover;111a, weak point;12, cup body;120, it is atomized Mouthful;121, inward flange;122, outward flange;123, the first conducting probe;13, bottom cover;130, access probe;
2, isolated part;21, cap;21a, weak point;22, encapsulating film;23, membrane layer
3, it is atomized mould group;30, atomizing piece;31, atomizing face mask seat;32, atomizing piece silica gel sheath;33, it is atomized mould group bottom cover; 34, screw;35, the second conducting probe.
Specific embodiment
The preferred embodiment of the utility model is described in detail with reference to the accompanying drawing, so that the advantages of the utility model It can be easier to be understood by the person skilled in the art with feature.It should be noted that for the explanation of these embodiments It is used to help understand the utility model, but does not constitute the restriction to the utility model.In addition, sheet disclosed below is practical new Involved technical characteristic can be combined with each other as long as they do not conflict with each other in each embodiment of type.
Embodiment 1
The present embodiment provides a kind of drug storage of nebulizer administration and atomising device, by medicine glass mould group, atomization mould group and Isolated part three parts are constituted.The drug storage of the nebulizer administration and atomising device can be used as independent device, in connection mist After changing device Host, directly the drug in medicine glass mould group can be atomized, then the atomization by connection on the apparatus Mask or suction nozzle are administered to patient.Isolated part is located between medicine glass mould group and atomization mould group, for only in atomized medicine introducing When allow medical fluid contact atomization mould group atomization part;The drug storage of the nebulizer administration and atomising device have atomized medicine introducing shape State, in atomized medicine introducing state, isolated part is pulled out, removes or destroys, medical fluid and atomization part contact in medicine glass.
In the present embodiment, medicine glass mould group and atomization mould group are integral types, and package parts are set up directly on medicine glass mould In group.Referring to shown in attached drawing 1-2, medicine glass mould group includes medicine glass 1, and medicine glass 1 is made of cup body 12, upper cover 11 and bottom cover 13, upper cover 11 and bottom cover 13 be respectively fixedly connected in the upper and lower ends portion of cup body 12 for being closed so that wherein forming one for containing Put the cavity of medical fluid.Wherein, the atomization mouth 120 being connected to cavity is offered on the side wall of cup body 12, offered in upper cover 11 with The air hole 110 of cavity connection, and upper cover 11 and one integrally formed or solid for closing the breather hole cover 111 of air hole 110 Fixed connection, is specially made of medical grade plastic cement.There is the breather hole cover 111 weak point 111a(to be particularly located at and upper cover 11 Junction), when by external force, it is broken at weak point 111a and breather hole cover 111 is made to be broken off and expose air hole 110.Make Used time can be such that breather hole cover 111 separates with upper cover 11 by certain strength (such as break, draw, pull), convenient for the drug of the inside Solution is poured out or is drawn.The middle part of bottom cover 13 is embedded with a pair of of access probe 130, is first for connecting atomization plant host A part of connecting component.Atomization plant host herein refers to the main part for not including the atomization plant of atomization mould group, Effect first is that drug storage to the nebulizer administration and atomising device provide electric signal.When the storage of the nebulizer administration After medicine and atomising device connection atomization plant host, access probe 130 obtains electric signal from atomization plant host and to described Mould group 3 is atomized to transmit.
Isolated part 2 is selected from one or more of cap, encapsulating film and membrane layer;Wherein, specific set-up mode It is as follows:
Cap be connected on the wall of cup of medicine glass 1 with close be atomized mouth 120, and cap have be broken after by external force Weak point;
Encapsulating film be arranged in being pulled out, be squeezed and deformed or puncture medicine glass 1 and atomization mould group 3 between or medicine glass 1 on or It is atomized in mould group 3;
Membrane layer covering is formed on atomization part and can be destroyed or remove.
In drug storage and atomising device specific to attached nebulizer administration shown in FIG. 1, have extremely on the outer wall of medicine glass 1 A few circle outward extends flange, and flange is arranged around atomization mouth 120, and isolated part 2 is arranged on flange.More specifically, mist Change mouth 120 to be provided on the side wall of cup body 12, flange is formed on the side wall of cup body 12, and isolated part 2 includes 21 He of cap Encapsulating film 22.The flange includes inward flange 121 and outward flange 122, and inward flange 121 is arranged around atomization mouth 120, outward flange 122 are arranged around inward flange 121, and isolated part 2 includes cap 21 and encapsulating film 22, and cap 21 is arranged in inward flange 121 Upper and cap 21 has the weak point 21a being broken after by external force, and encapsulating film 22 is arranged on the outward flange 122 and can It is punctured or is squeezed and deformed, successively covering is atomized mouth 120 for both cap 21 and encapsulating film 22.In use, medicine glass 1 is atomized mouth 120 encapsulating film 22 and cap 21 can be separated by certain strength with medicine glass 1.
Being atomized mould group 3 is the component containing atomizing piece 30.The atomizing piece 30 being atomized in mould group 3, preferably piezoelectric ceramics mist Change piece.It is micron-sized multiple micropores that uniform, diameter is distributed on atomizing piece 30, the size of micropore be 5 microns hereinafter, These micropore close-packed arrays are in net distribution.The atomizing piece 30 is set in atomizing piece silica gel sheath 32, and atomizing piece silica gel sheath 32 is set In in atomization mould group bottom cover 33.Atomizing piece 30 passes through fixed primary screw 34 and is fixed in atomizing piece silica gel sheath 32.
The first conducting probe of a pair 123 of electrical connection corresponding with access probe 130 is equipped in the atomization mouth 120 of medicine glass 1, First conducting probe 123 is telescopic.Atomization mould group 3 includes the conductive spy of a pair second powered to piezoelectric ceramic atomizer patch 30 Needle 35, when the atomized medicine introducing device is in atomized medicine introducing state, cap 21 and encapsulating film 22 are removed, the first conducting probe 123 and second conducting probe 35 directly connect, by the electric signal transmission of atomization plant host to atomizing piece 30.First conducting probe 123 be specially telescopic conducting probe, is preferably placed at the medium position of atomization mouth 120, can change position by sliding, be convenient for Connect with the second conducting probe 35 of atomization mould group 3.It is further preferred that the first conducting probe 123 and the second conducting probe 35 It arranges in parallel and in the horizontal direction.Second conducting probe 35 is connect by the space at 32 middle part of atomizing piece silica gel sheath with atomizing piece 30 Touching.Second connecting portion part includes atomizing face mask seat 31, and 30 other side of atomizing piece is communicated with atomizing face mask seat 31.Access probe 130 It can also be directly electrically connected by conducting wire with the second conducting probe 35, and be not provided with the first conducting probe 123.
This embodiment offers medicine glass mould group separable and being applied in combination and atomization 3 forms of mould group, i.e., the two is in clinic Two components are independent before atomized medicine introducing.In use, medicine glass mould group can form a whole with atomization mould group 3, connection is free of After the atomization plant host of atomizing piece 30, atomization directly can be realized to the liquid medicine in medicine glass mould group.
Embodiment 2
Referring to shown in attached drawing 3, substantially with embodiment 1, the difference with embodiment 1 is only that the present embodiment:
It uses using mutual separable medicine glass mould group and atomization 3 form of mould group and after combining, in medicine glass mould group not Encapsulating film is set, is at this time mainly isolated from the outside medical fluid by cap 21, it is right with atomization mould group 3 after breaking cap 21 It is connected into one, connects atomization plant host, realizes the atomization to medical fluid.
Embodiment 3
Referring to shown in attached drawing 4, substantially with embodiment 1, the difference with embodiment 1 is only that the present embodiment:
Medicine glass 1 and atomization mould group 3 are assembled into one during manufacturing, inseparable during drug storage and transport, Medicine glass mould group is free of cap 21, encapsulating film 22 and inward flange 121, but is arranged on 30 surface of atomizing piece of atomization mould group 3 One layer of membrane layer 23, atomization mould group 3 are plugged in outward flange 122, the first conducting probe 123 and the direct phase of the second conducting probe 35 It connects.In use, removing or destroying membrane layer 23, contact drug solution directly with atomizing piece 30, connects and be free of atomizing piece 30 Atomization plant host after, can directly in medicine glass mould group liquid medicine realize atomization.
In addition to this, mode is also implemented as follows:
Medicine glass 1 and atomization mould group 3 are assembled into one during manufacturing, inseparable during drug storage and transport, Medicine glass mould group is free of cap 21 and the first conducting probe 123, and the second conducting probe 35 being atomized in mould group 3 is direct by conducting wire It is electrically connected with the access probe 130 in medicine glass mould group, in use, by specific mode, by the encapsulating film 22 in medicine glass mould group Removal destroys, and contacts drug solution directly with atomizing piece 30, can be with after connecting the atomization plant host for being free of atomizing piece 30 Atomization directly is realized to the liquid medicine in medicine glass mould group.
Medicine glass mould group described in the utility model and atomization mould group 3, the two are combined with each other into one kind and carry out mist to drug solution The device of change.Medicine glass 1 is atomized mouth 120 and removes encapsulating film 22 and atomization 120 cap 21 of mouth, and atomization mould group 3 removes atomization mould group After bottom cover 33, the two is mutually butted, and comes into full contact with medical fluid and atomizing piece 30 in medicine glass 1.Atomizing piece 30 is free of when connecting After atomizer host, atomization, the including but not limited to means such as injection, mesh or ultrasound can be driven by various methods, is realized Atomization to medical fluid.Preferably, the medicine glass mould group and atomization mould group 3 be independent component, using it is preceding by seamless interfacing after Medical fluid is realized and is atomized.It is further preferred that the atomization driving force of the atomization mould group 3 is mesh atomization.
The utility model provides a kind of novel medical fluid packaged form for drug production, i.e., by drug sterile production Drug is contained in medicine glass 1 in the process, is isolated from the outside by encapsulating film 22, realizes Preservation in sterile condition and the transport of drug.This Utility model is independent from atomization plant by the atomizing piece 30 of the drug storage of nebulizer administration and atomising device, with medicine glass Mould group is combined into the novel drug solution storage of one kind and atomising device.
Medicine glass mould group and atomization mould group 3 are separable component, and using preceding removal isolated part 2, the two is combined into one, After medical fluid is contacted with atomizing piece 30, the atomization of drug is realized.During drug packages, it is preferred that each medicine glass mould group is equipped with One atomization mould group 3.In addition it is also possible to be equipped with medicine glass mould group according to the course for the treatment of of drug and be atomized the quantity of mould group 3.
Medicine glass mould group described in the utility model and atomization mould group 3 are also possible to inseparable entirety, produce in drug In the process for holding drug solution.There is encapsulation between the drug solution in medicine glass mould group and the atomizing piece 30 for being atomized mould group 3 Film 22 or membrane layer, to prevent drug solution from contacting with the direct of atomizing piece 30.In use, by specific mode, including but It is not limited to the modes such as puncture, remove, extract, squeezing, after contacting drug solution directly with atomizing piece 30, passes through atomization plant master The electric signal that machine provides realizes the atomization to drug solution.
The above embodiments are only for explaining the technical ideas and features of the present invention, is a kind of preferred embodiment, mesh Be that person skilled in the art can understand the content of the utility model and implement accordingly, this reality can not be limited with this With novel protection scope.Equivalent transformation or modification made by all principles according to the present utility model should all be covered practical at this Within novel protection scope.

Claims (10)

1. drug storage and the atomising device of a kind of nebulizer administration characterized by comprising
Medicine glass mould group comprising there is the medicine glass for holding the cavity of medical fluid, offered and the cavity phase on the medicine glass Logical atomization mouth;
It is atomized mould group comprising for by the atomization part of medical liquid atomizing;
Isolated part, for only allowing medical fluid to contact in atomized medicine introducing between the atomization mouth and the atomization mould group The atomization part;
Wherein, the drug storage and atomising device have atomized medicine introducing state, and in atomized medicine introducing state, the isolated part is taken out From, removal or destroying, the medical fluid and the atomization part in the medicine glass contact,
The medicine glass mould group further includes first connecting portion part for connecting atomization plant host;The atomization mould group further includes using In connection atomizing face mask or the second connecting portion part of suction nozzle.
2. drug storage and the atomising device of nebulizer administration according to claim 1, which is characterized in that the isolation part Part is selected from one or more of cap, encapsulating film and membrane layer;Wherein:
The cap is connected on the wall of cup of the medicine glass to close the atomization mouth, and the cap has by outer The weak point being broken after power;
The encapsulating film is arranged between the medicine glass and the atomization mould group or described in which can be pulled out, be squeezed and deformed or puncture On medicine glass or in the atomization mould group;
The membrane layer covering is formed on the atomization part and can be destroyed or remove.
3. drug storage and the atomising device of nebulizer administration according to claim 1, which is characterized in that the atomization part For piezoelectric ceramic atomizer patch, a large amount of micropore is distributed on the piezoelectric ceramic atomizer patch.
4. drug storage and the atomising device of nebulizer administration according to claim 3, which is characterized in that described first connects Relay part includes at least a pair of for connecting with the atomization plant host to obtain the access probe of electric signal.
5. drug storage and the atomising device of nebulizer administration according to claim 4, which is characterized in that on the medicine glass At least a pair of first conducting probe equipped with electrical connection corresponding with the access probe, the atomization mould group includes to the pressure Electroceramics atomizing piece provides at least a pair of second conducting probe of electric signal, when the atomized medicine introducing device is in atomized medicine introducing state When, first conducting probe and second conducting probe connect.
6. drug storage and the atomising device of nebulizer administration according to claim 4, which is characterized in that the atomization mould Group includes that at least a pair of second conducting probe of electric signal is provided to the piezoelectric ceramic atomizer patch, when the atomized medicine introducing device In atomized medicine introducing state, the access probe is connected by conducting wire and second conducting probe.
7. drug storage and the atomising device of nebulizer administration according to claim 1, which is characterized in that the medicine glass There is at least one circle to outward extend flange, the flange is arranged around the atomization mouth, the isolated part setting on outer wall On the flange.
8. drug storage and the atomising device of nebulizer administration according to claim 7, which is characterized in that the flange packet Inward flange and outward flange are included, the inward flange is arranged around the atomization mouth, and the outward flange is arranged around the inward flange, institute Stating isolated part includes cap and encapsulating film, the cap is arranged on the inward flange and the cap have by The weak point being broken after to external force, the encapsulating film are arranged on the outward flange and can be punctured or be squeezed and deformed.
9. drug storage and the atomising device of nebulizer administration according to claim 1, which is characterized in that described second connects Relay part includes atomizing face mask seat.
10. drug storage and the atomising device of nebulizer administration according to claim 1, which is characterized in that the medicine glass On be also provided with air hole, the medicine glass, which is equipped with, exposes the air hole for closing the air hole and can be removed Medicine glass cap.
CN201720845057.0U 2017-07-12 2017-07-12 The drug storage of nebulizer administration and atomising device Active CN208405629U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201720845057.0U CN208405629U (en) 2017-07-12 2017-07-12 The drug storage of nebulizer administration and atomising device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201720845057.0U CN208405629U (en) 2017-07-12 2017-07-12 The drug storage of nebulizer administration and atomising device

Publications (1)

Publication Number Publication Date
CN208405629U true CN208405629U (en) 2019-01-22

Family

ID=65126715

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201720845057.0U Active CN208405629U (en) 2017-07-12 2017-07-12 The drug storage of nebulizer administration and atomising device

Country Status (1)

Country Link
CN (1) CN208405629U (en)

Similar Documents

Publication Publication Date Title
CN206026818U (en) Atomizer
CN110339438A (en) It is a kind of to treat the antiviral with nasal cavity and nasal sinus Congestant spraying device of flu
CN106620970A (en) Portable atomization and administration device
CN107213538A (en) The drug storage of nebulizer administration and atomising device
CN113768910B (en) Pharmaceutical assembly comprising formoterol fumarate inhalation solution and use thereof
CN204446846U (en) A kind of disposable per nasal brain-targeted drug delivery device
CN106730188A (en) A kind of Respiratory Medicine is atomized chemical spraying device
CA2821994C (en) Filtering powdered medicament inhaler and application
CN208405629U (en) The drug storage of nebulizer administration and atomising device
CN201727816U (en) Medical atomization device
CN111840715A (en) Combined portable inhalation device containing disposable special bottle for atomized medicament
CN203507247U (en) Nebulizer special for mechanical ventilation
CN210009471U (en) Atomizing inhaler capable of freely switching medicaments
CN207970317U (en) A kind of children's atomization therapeutic device
CN204446844U (en) Disposable per nasal brain-targeted drug delivery device
CN212416581U (en) Combined portable inhalation device containing disposable special bottle for atomized medicament
CN203139376U (en) Medicator for gynecology department
CN204521853U (en) A kind of autogenous cutting formula nebulizer
CN205994825U (en) A kind of aerosol apparatus
TW201427733A (en) Medical micro-mesh nebulizer capable of effectively controlling the output ofultra-fine particles atomization
KR101659741B1 (en) Powder medicament mouthpiece container and application
CN211327626U (en) Atomizing mask capable of separating medicine
CN207640760U (en) Gas compression formula children's nebulizer
CN2834590Y (en) A medical atomizer
CN201775843U (en) Push-type medicine mist generating device for medical treatment and pushing mechanism thereof

Legal Events

Date Code Title Description
GR01 Patent grant
GR01 Patent grant
CP01 Change in the name or title of a patent holder
CP01 Change in the name or title of a patent holder

Address after: Unit 304, 305, 306-2, 307, 3rd floor, No. 12, helix 3 Road, International Biological Island, Guangzhou, Guangdong 510320

Patentee after: Suno biomedical technology (Guangzhou) Co.,Ltd.

Patentee after: CHANGZHOU ZHENGYUAN MEDICAL TECHNOLOGY Co.,Ltd.

Address before: Unit 304, 305, 306-2, 307, 3rd floor, No. 12, helix 3 Road, International Biological Island, Guangzhou, Guangdong 510320

Patentee before: GUANGZHOU NANOTIDES PHARMACEUTICALS Co.,Ltd.

Patentee before: CHANGZHOU ZHENGYUAN MEDICAL TECHNOLOGY Co.,Ltd.